Laboratory operator Quest Diagnostics raised its full-year forecast for profit and revenue on Tuesday, banking on robust demand for its diagnostic tests.

Strong growth, raised guidance, and new partnerships signal continued momentum amid regulatory and cost headwinds.

Quest Diagnostics Inc.’s DGX third-quarter 2025 adjusted earnings per share (EPS) of $2.60 beat the Zacks Consensus Estimate by 3.59%. The metric also exceeded the year-ago adjusted figure by 13%.

ATLANTA — CLEAR, a security technology company, has partnered with Wellstar Health to streamline check-ins at local medical ...

If I could give zero stars, I would. I visited the lab yesterday to specifically ask if they had experience drawing blood from a 15-month-old child. They confidently assured me that their staff was ...

United Airlines will replace its entire Boeing 737-800 fleet with Boeing 737 MAX 8 aircraft and upgrade its check-in lobby with new kiosks "transforming the travel experience on the ground and in the ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

Human rights are under assault [...] This year’s theme reminds us that human rights are about building the future — right now [...] We must stand up for all rights — always." UN Secretary-General ...

Some people find that taking CBD in tincture form helps it absorb faster than eating a CBD gummy or applying it topically. If you’re in the market for a full-spectrum CBD tincture, you have options.